Neurogranin activators encompass a class of chemicals that either directly or indirectly modulate the activity of Neurogranin, a critical protein in synaptic plasticity and cognitive function. These activators work through various biochemical pathways, primarily focusing on influencing the signaling cascades that Neurogranin is part of or interacts with. The primary mechanism through which these chemicals act is by modulating the phosphorylation status of Neurogranin or influencing its interaction with calmodulin, a key binding partner. For instance, compounds like Forskolin and Rolipram elevate cAMP levels, subsequently activating PKA, which phosphorylates Neurogranin, enhancing its regulatory role in synaptic signaling. In contrast, compounds like H-89 and KN-93, which target PKA and CaMKII respectively, indirectly affect Neurogranin's phosphorylation and its functional dynamics.
Moreover, other compounds, such as Nimodipine and Calmidazolium Chloride, influence Neurogranin's activity by altering calcium signaling pathways, a crucial aspect of Neurogranin's function. Nimodipine, a calcium channel blocker, and Calmidazolium Chloride, a calmodulin antagonist, showcase the intricate relationship between calcium signaling and Neurogranin's role in the brain. Furthermore, growth factors like NGF and BDNF, though not direct activators, play a significant role in modulating Neurogranin's expression and function in neuronal development and synaptic plasticity. Similarly, hormones like Estrogen and Testosterone indirectly influence Neurogranin's activity through their receptor-mediated effects on neuronal functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Stimulates adenylyl cyclase, increasing cAMP levels. This activates PKA, which phosphorylates Neurogranin, enhancing its interaction with calmodulin and synaptic plasticity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
A PDE4 inhibitor, prevents cAMP breakdown, leading to PKA activation and subsequent phosphorylation of Neurogranin, modulating its activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Potent PKA inhibitor, indirectly affecting Neurogranin's phosphorylation status and its interaction with calmodulin. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Selective CaMKII inhibitor, indirectly affects Neurogranin's role in synaptic plasticity through modulation of CaMKII activity, a key kinase for Neurogranin phosphorylation. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmodulin antagonist, inhibits calmodulin-dependent processes influencing Neurogranin and calmodulin interaction. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Calcium channel blocker, indirectly influences calcium signaling pathways and therefore the calcium/calmodulin-dependent activities of Neurogranin. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Influences glucose metabolism and neuronal functions, indirectly impacting Neurogranin's role in synaptic plasticity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Affects neuronal functions, including synaptic plasticity. Its receptor-mediated actions can influence Neurogranin activity, especially in memory and learning processes. | ||||||